000 | 03971nam a22002777a 4500 | ||
---|---|---|---|
003 | OSt | ||
005 | 20240305192441.0 | ||
008 | 220601b |||||||| |||| 00| 0 eng d | ||
020 | _a3319311905 | ||
020 | _a9783319311906 | ||
040 | _cdlc | ||
100 |
_aPaul S. Giacomini _938335 |
||
245 | _aCase Studies in Multiple Sclerosis | ||
250 | _aillustrated | ||
260 |
_aMontreal Neurological Hospital and Institute McGill University Health Centre McGill University Montreal, Quebec, Canada _bSpringer _c2016 |
||
300 | _a 149 pages | ||
505 | _aContents: Preface Clinically Isolated Syndrome 1 Optic neuritis 2 Myelitis Early Multiple Sclerosis 3 Diseasemodifying therapies 4 Management of relapses withcorticosteroids Established RelapsingRemitting Multiple Sclerosis 10 Diagnosing secondary progressive multiple sclerosis 11 Walking disability in multiplesclerosis 12 Cognitive impairment Pediatric Multiple Sclerosis and Related Disorders 13 Acute disseminatedencephalomyelitis 14 Pediatric multiple sclerosis 15 Pediatric multiple sclerosis mimics Pregnancy and Multiple Sclerosis 5 Breakthrough disease 6 Progressive multifocalleukoencephalopathy 7 Induction therapy Primary Progressive Multiple Sclerosis 8 Diagnosing primary progressive multiple sclerosis 9 Symptomatic care in primary progressive multiple sclerosis Secondary Progressive Multiple Sclerosis 16 Prenatal planning in multiplesclerosis 17 Multiple sclerosis therapies and pregnancy 18 Postpartum issues with multiple sclerosis Other Multiple SclerosisRelated Disorders 19 Neuromyelitis optica | ||
520 |
_aThis handbook is a collection of clinical narratives that underscore the heterogeneous and unpredictable presentation of multiple sclerosis (MS) and give real-world clinical context to recent drug developments. This accessible and concise publication is intended to be used by a wide range of medical professionals, from specialist neurologists to medical trainees with an interest in neurology. An ideal clinical resource, Case Studies in Multiple Sclerosis provides an evidence-based discussion of each case, with an aim to enhance effective diagnosis and treatment of patients with MS and MS-related conditions. _bCommon terms and phrases: acute ADEM alemtuzumab Ann Neurol antibody assessment attempting conception bilateral brain MRI brainstem cerebrospinal fluid Clinical pearls clinical trials clinically isolated syndrome corticosteroids diagnosis diagnostic criteria disability disease activity disorders DMTs EDSS enhancement etal evaluation examination fampridine fingolimod follow-up gadolinium gadolinium-enhancing glatiramer acetate imaging infection inflammatory interferon beta-1a International Publishing Switzerland intravenous Investigations involvement juxtacortical lesions lesions on MRI long-term McDonald criteria medications methylprednisolone mild MRI lesions multiple sclerosis MultScler myelitis natalizumab Neurology neuromyelitis optica neuropathic pain normal Ó Springer O’Connor oligoclonal bands onset optic nerve optic neuritis Outcome P.S. Giacomini periventricular placebo-controlled Polman CH pregnancy primary progressive progressive multifocal leukoencephalopathy progressive multiple sclerosis Publishing Switzerland 2017 relapsing-remitting multiple sclerosis secondary progressive spinal cord SPMS Springer International Publishing Studies in Multiple Study Group Switzerland 2017 P.S. T2 hyperintense T2 lesions teriflunomide testing therapeutic treatment typical visual white matter worsening |
||
600 |
_x Medical / Practice Management & Reimbursement _926757 |
||
600 |
_xMedical / Neurology _926948 |
||
600 |
_xMedical / Family & General Practice _926950 |
||
600 |
_x Medical / Clinical Medicine _926816 |
||
600 |
_xMedical / Allied Health Services / Imaging Technologies _926763 |
||
600 |
_xMedical › Allied Health Services › Imaging Technologies _926754 |
||
942 |
_2ddc _cEB |
||
999 |
_c6831 _d6831 |